UC Davis Comprehensive Cancer Center
4501 X Street, 2nd Floor
Sacramento, CA 95817
Additional Phone Numbers
Philosophy of Care
Dr. Hoeg believes in high quality, innovative, and compassionate care of his patients. Dr. Hoeg believes in a team-based approach to patient care, utilizing expertise of nurses, pharmacists, social workers, and consultants to provide complete care for his patients.
Dr. Hoegs’ clinical interests include: Bone Marrow Transplant and other hematologic malignancies.
Dr. Hoeg's research interest is in Infectious Disease of Bone Marrow Transplant.
Hematology and Oncology
M.D., University of Copenhagen, Copenhaven, Denmark 2005
B.A., University of Copenhagen, Copenhagen, Denmark 1998
Internship: Internal Medicine, Gundersen Lutheran Medical Foundation, La Crosse WI 2005-2006
Internal Medicine, Gundersen Lutheran Medical Foundation, La Crosse WI 2006-2008
Hematology, University of Copenhagen, Copenhagen Denmark 2009-2013
American Board of Internal Medicine- Diplomat, Hematology/Oncology,
DEA License, 2015
Medical Board of California, 2015
American College of Physicians
Danish Medical Society
Danish Society of Emergency Medicine
Danish Society of Hematology
Select Recent Publications
R. T. Hoeg, J. A. Lee, M. A. Mathiason, K. Rokkones, S. L. Serck, K. L. Crampton, A. Emmel, A. J. Jumonville, E. A. Severson, R. S. Go: Outcome of phase II oncology clinical trial abstracts presented at annual meeting of the American Society of Clinical Oncology (ASCO). Am J Clin Oncol. 2009 Jun;32(3):253-7.
R.T. Hoeg, A.M. Skau, P. Nørgaard, P.B. Hansen: ”Complete Remission of diffuse large B-Cell Lymphoma After Eradication of Helicobactor Pylori.” J of the Danish Medical Association. 2011 173:2425-6
Raghavendra M, Hoeg RT, Bottner WA, Agger WA. Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care. Wisconsin Medical Journal. 2014 Apr;113(2):53-8.
R.T. Hoeg, A. Andersen, E.B. Leinøe, H. Birgens: “Measuring the Impact of a Restrictive Transfusion Guideline in Patients with Acute Myeloid Leukemia” Vox Sanguinis 2013 Jul:105(1):81-4